7.25
0.68%
-0.05
Dopo l'orario di chiusura:
7.25
Pulmonx Corp Borsa (LUNG) Ultime notizie
Pulmonx Co. (NASDAQ:LUNG) Shares Sold by Swiss National Bank - Defense World
Defense World
Pulmonx Co. (NASDAQ:LUNG) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Defense World
Company’s Banking Stock: Dissecting a -19.55% Quarterly Revenue Decline Amid Growth - The InvestChronicle
The InvestChronicle
Balance Sheet Insights: Pulmonx Corp (LUNG)'s Debt-to-Equity and Long-Term Debt/Eq Ratios – DWinneX - The Dwinnex
The Dwinnex
Franklin Resources Inc. Sells 1461 Shares of Pulmonx Co. (NASDAQ:LUNG) - Defense World
Defense World
Quest Partners LLC Makes New Investment in Pulmonx Co. (NASDAQ:LUNG) - Defense World
Defense World
Dynamic Technology Lab Private Ltd Buys New Position in Pulmonx Co. (NASDAQ:LUNG) - Defense World
Defense World
Pulmonx exec sells over $10,000 in company stock By Investing.com - Investing.com
Investing.com
Pulmonx exec sells over $10000 in company stock - Investing.com India
Investing.com India
Insider Selling: Pulmonx Co. (NASDAQ:LUNG) Insider Sells 1,184 Shares of Stock - MarketBeat
MarketBeat
Insider Selling: Pulmonx Co. (NASDAQ:LUNG) Insider Sells 1,184 Shares of Stock - MarketBeat
MarketBeat
Pulmonx exec sells over $10,000 in company stock By Investing.com - Investing.com
Investing.com
How Much Upside is Left in Pulmonx (LUNG)? Wall Street Analysts Think 80.3%
Zacks Investment Research
Russell Investments Group Ltd. Sells 12472 Shares of Pulmonx Co. (NASDAQ:LUNG) - Defense World
Defense World
Citigroup Maintains Pulmonx (LUNG) Buy Recommendation - MSN
MSN
Pulmonx Co. (NASDAQ:LUNG) Shares Acquired by New York State Common Retirement Fund - Defense World
Defense World
FDA approves Pulmonx's valve to treat lung disease - Yahoo News UK
Yahoo News UK
Victory Capital Management Inc. Has $10.89 Million Stock Position in Pulmonx Co. (NASDAQ:LUNG) - Defense World
Defense World
Victory Capital Management Inc. Has $10.89 Million Stock Position in Pulmonx Co. (NASDAQ:LUNG) - Defense World
Defense World
FDA approves Pulmonx's valve to treat lung disease - Yahoo News UK
Yahoo News UK
5 Medical Info Systems Stocks to Buy for Stable Returns
Zacks Investment Research
LUNG's Stock Dilemma: Pulmonx Corp's Market Performance and Outlook – Invest Chronicle - The InvestChronicle
The InvestChronicle
Pulmonx Co. (NASDAQ:LUNG) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Defense World
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Wall Street Analysts See a 56.11% Upside in Pulmonx (LUNG): Can the Stock Really Move This High? - Yahoo Finance
Yahoo Finance
Earnings Update: Pulmonx Corporation (NASDAQ:LUNG) Just Reported Its First-Quarter Results And Analysts Are ... - Yahoo Finance
Yahoo Finance
Pulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Pulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call Transcript - Insider Monkey
Insider Monkey
Canaccord Genuity lowers target for Pulmonx shares, reamains bullish on solid Q1 results - Investing.com South Africa
Investing.com South Africa
Canaccord Genuity lowers target for Pulmonx shares, reamains bullish on solid Q1 results - Investing.com Australia
Investing.com Australia
Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
Pulmonx Corporation (LUNG) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance Australia
Yahoo Finance Australia
Pulmonx Corp [LUNG] Insider Activity: An Update for Investors – Knox Daily - Knox Daily
Knox Daily
LUNG's latest rating updates from top analysts. – Knox Daily - Knox Daily
Knox Daily
Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024
GlobeNewswire Inc.
LUNG Stock Quote Price and Forecast - CNN
CNN
Navigating 6 Analyst Ratings For Pulmonx
Benzinga
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
GlobeNewswire Inc.
Pulmonx names new CFO to bolster financial leadership - Investing.com
Investing.com
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Steven Cohen's Point72 Asset Management Bolsters Position in Pulmonx Corp - Yahoo Finance
Yahoo Finance
Analyst Ratings For Pulmonx
Benzinga
Pulmonx Full Year 2023 Earnings: Beats Expectations - Yahoo Finance
Yahoo Finance
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire Inc.
Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer
GlobeNewswire Inc.
Pulmonx Corp (LUNG) Reports Solid Revenue Growth Amidst Increased Operating Expenses - Yahoo Finance
Yahoo Finance
Omnicell (OMCL) Tops Q4 Earnings and Revenue Estimates
Zacks Investment Research
Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
GlobeNewswire Inc.
Insider Sell: President and CEO French Glendon E. III Sells 10,000 Shares of Pulmonx Corp (LUNG) - Yahoo Finance
Yahoo Finance
Capitalizzazione:
|
Volume (24 ore):